Try our Advanced Search for more refined results

Alkermes Raises Revenue Forecast After Arbitration Award

By Ali Sullivan (June 6, 2023, 9:03 PM EDT) -- Biopharmaceutical company Alkermes PLC on Tuesday boosted its financial forecast for 2023 by $425 million after the company said it wrapped arbitration proceedings with Johnson & Johnson subsidiary Janssen Pharmaceutica NV over two license agreements for small particle pharmaceutical compound technology that Janssen uses in antipsychotic, schizophrenia and HIV drugs....

Law360 is on it, so you are, too.

A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.


A Law360 subscription includes features such as

  • Daily newsletters
  • Expert analysis
  • Mobile app
  • Advanced search
  • Judge information
  • Real-time alerts
  • 450K+ searchable archived articles

And more!

Experience Law360 today with a free 7-day trial.

Start Free Trial

Already a subscriber? Click here to login

Related Sections

Companies

Hello! I'm Law360's automated support bot.

How can I help you today?

For example, you can type:
  • I forgot my password
  • I took a free trial but didn't get a verification email
  • How do I sign up for a newsletter?
Ask a question!